FDA Brief

Warning letters Drugs

FDA warning letter to

Hua Da Trading, Inc.

High riskIssued Dec 20, 2023Posted Dec 26, 2023Center for Drug Evaluation and Research | CDER

FDA warned Hua Da Trading over WeFun, an unapproved drug sold as a supplement that contains undeclared sildenafil.

What happened

FDA reviewed https://www.eshoponlineusa.com from July to December 2023 and obtained a sample and labeling of "WeFun." Laboratory analysis found the sample contained undeclared sildenafil, the active ingredient in Viagra, while the product was marketed as a dietary supplement. FDA also noted the website offered other named products but said it had not sampled those from the company's inventory.

What FDA found

  1. WeFun is a new drug sold without FDA approval, and FDA says no approved application is in effect for it.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. Because sildenafil was approved as a drug before being marketed as a supplement or food, WeFun cannot be a dietary supplement.

    FD&C Act section 201(ff)(3)(B)(i), 21 U.S.C. 321(ff)(3)(B)(i)
  3. WeFun's labeling lacks adequate directions for safe use by a layperson, and the product is a prescription drug because it contains sildenafil.

    FD&C Act section 502(f)(1), 21 U.S.C. 352(f)(1); 21 CFR 201.100(c)(2) and 201.115
  4. FDA says WeFun is misbranded because its labeling is false or misleading and does not disclose that it contains a prescription drug ingredient.

    FD&C Act section 502(a), 21 U.S.C. 352(a); section 201(n), 21 U.S.C. 321(n)
  5. WeFun's labeling lacks adequate warnings for users, especially because users would not know about the undeclared drug ingredient.

    FD&C Act section 502(f)(2), 21 U.S.C. 352(f)(2)
  6. Selling this misbranded drug in interstate commerce is a prohibited act.

    FD&C Act section 301(a), 21 U.S.C. 331(a)

What FDA wants

FDA asks the company to submit a written response within fifteen working days of receipt, explaining the steps taken to fix the violations, prevent recurrence, and provide related documentation; if it disputes the findings, it must include reasoning and supporting information.

Who should pay attention

  • retailers and online sellers of male enhancement supplements
  • brands that buy or distribute supplements from Hua Da Trading
  • consumers who use products marketed as natural male energy supplements

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  2. Supercore Products Group, Inc.

    FDA warns Supercore that Hard Steel and Gold Hard Steel Plus are unapproved, mislabeled drugs with hidden sildenafil; Hard Steel also has acetaminophen.

    High risk
  3. Amazon.com, Inc.

    FDA warned Amazon that energy supplements sold on its site contained undeclared sildenafil or tadalafil, making them unapproved and misbranded drugs.

    High risk
  4. Distributor RFR, LLC

    FDA: Distributor RFR's SANGTER male energy supplement contained undeclared sildenafil, making it an unapproved, misbranded new drug.

    High risk